Monographie - Penicillin G sodium

Ultimele actualizari :
19/11/2024

Penicillin G sodium

Formula chimica

Denumirea comerciala

Trade names are indicative and excipients composition can be different depending on the country and manufacturers

Benapen	Brazilia
Bencilpenicilina	Chilli, Ecuador, Peru
Benpen	Australia, noua Zeelandă
Bensylpenicillin	Suedia
Benzapen	Iran
Benzatec	Africa de Sud
Benzatron	Brazilia
Benzylpenicillin	Danemarca, Egipt, Finlanda, Norvegia, Suedia
Benzylpenicilline	Tunisia
Biconcillina	Ecuador
Crystapen	Canada, Irlanda, Marea Britanie
Declin	Mexic
Fortepen	Arabia Saudita
Geepenil	Finlanda
Natrium penicillin G	Olanda
Novopen	Africa de Sud
Pebencil	Venezuela
Penbendox	Mexic
Penibiot	Spania
Penicillin	Norvegia
Penicillina G sodica	Argentina, Chilli, Columbia, Ecuador, Portugalia
Penilevel	Spania
Sodiopen	Spania
Unicillina	Spania

Bibliografie : Penicillin G sodium

	tip	publicare
13	ziar	Stiles ML, Allen LV. Stability of nafcillin sodium, oxacillin sodium, penicillin G potassium, penicillin G sodium and tobramycin sulfate in polyvinyl chloride drug reservoirs. Am J Health-Syst Pharm 1997 ; 54: 1068-1070.
440	ziar	Stiles ML, Tu YH, Allen LV. Stability of cefazolin sodium, cefoxitin sodium, ceftazidime, and penicillin G sodium in portable pump reservoirs. Am J Hosp Pharm 1989 ; 46: 1408-1412.
1057	ziar	Cutie MR. Compatibility of verapamil hydrochloride injection with commonly used additives. Am J Hosp Pharm 1983 ; 40: 1205-1207.
1072	ziar	Saltsmann CL, Tom CM, Mitchell A, Fan JH, Gailey RA. Compatibility of levofloxacin with 34 medications during simulated Y-site administration. Am J Health-Syst Pharm 1999 ; 56: 1458-1459.
1241	ziar	Rayani S, Jamali F. The stability of penicillin G sodium in 5% dextrose in water minibags after freezing. Can J Hosp Pharm 1985 ; 38: 162-163.
1263	ziar	Allwood MC, Brown PW. The effect of buffering on the stability of reconstituted benzylpenicillin injection. Int J Pharm Pract 1992 ; 1: 242-244.
1725	ziar	Oliver C, Law S. Compatibility of oxytocin, zidovudine, and penicillin G. Can J Hosp Pharm 2001 ; 54: 112-113.
2056	ziar	Vella-Brincat JWA, Begg EJ, Gallagher K, kirkpatrick CMJ, Zhang M, Frampton C, Chambers ST. Stability of benzylpenicillin during continuous home intravenous therapy. J Antimicrob Chemother 2004 ; 53: 675-677.
2087	ziar	Ferreira E, Forest JM, Hildgen P. Compatibility of dimenhydrinate injectable by Y administration. Pharmactuel 2004 ; 37: 17-20.
2090	ziar	Pere H, Chasse V, Forest JM, Hildgen P. Compatibility of injectable pantoprazole in Y-site administration. Pharmactuel 2004 ; 37: 193-196.
3012	ziar	Sullivan T, Forrest J.M, Leclair G. Compatibility of Cloxacillin Sodium with Selected Intravenous Drugs During Simulated Y-Site Administration Hosp Pharm 2015 ; 50, 3: 214-220.
3227	ziar	Simon B, Hancu G, Gy?resi A. Application of capillary electrophoresis to the simultaneous determination and stability study of four extensively used penicillin derivatives Braz J Pharm Sci 2014 ; 50, 3 : 521-527.
3520	Laborator	Cidomycin - Summary of product Chracteristics. Sanofi 2011
3529	Laborator	Ciprofloxacin – Summary of Product Characteristics Hospira 2013
3540	Laborator	Heparin sodium - Summary of Product Characteristics. Wockhardt 2010
3549	Laborator	Amikacine B Braun - Résumé des caractéristiques du produit. B Braun 2012
3580	Laborator	Cytarabine Accord - Résumé des caractéristiques du produit Accord Healthcare France 2016
3585	Laborator	Benzylpenicillin sodium - Summary of Product Characteristics Genus Pharmaceuticals 2008
3643	Laborator	Gentamicin sulphate (Cidomycin®) - Summary of Product Characteristics Sanofi 2015
3648	ziar	Hossain M.A, Friciu M, Aubin S, Leclair G. Stability of penicillin G sodium diluted with 0.9% sodium chloride injection or 5% dextrose injection and stored in polyvinyl chloride bag containers and elastomeric pump containers. Am J Health-Syst Pharm 2014 ; 71:669-673.
3674	Laborator	Erythromycin lactobionate - Summary of Product Characteristics PanPharma 2016
3702	ziar	McDougall D.A.J, McWhinney. Stability of buffered benzylpenicillin solutions for outpatient parenteral antimicrobial therapy. J Pharm Pract and Res 2014 ; 44, 1: 26-28.
3931	Laborator	Trimébutine (Débridat®) - Résumé des caractéristiques du produit Pfizer Laboratoire 2016
3964	ziar	Audet M.A, Forest E, Friciu M, Forest J.M, Leclair G. Compatibilité du citrate de caféine injectable avec plusieurs autres médicaments. Pharmactuel 2017 ; 50,1 : 27-33.
4154	Laborator	Bleomycin sulfate- Summary of Product Characteristics Accord Health Care 2018
4319	ziar	Lessard J-J, Caron E, Schérer H, Forest J-M, Leclair G. Compatibility of Y-site Injection of Meropenem Trihydrate With 101 Other Injectable Drugs. Hosp Pharm 2020 ; 55, 5: 332-337.
4389	ziar	Côté K, Correal F, Metras M.E, Friciu M, Forest J.M, Leclair G. Compatibilité physique des médicaments administrés en Y aux soins intensifs, en particulier la dexmédétomidine, le lévosimendan et la kétamine. Pharmactuel 2019 ;52,4:206-213
4590	ziar	Smith E.K, McWhinney MPhil B.C. Stability of buffered benzylpenicillin and flucloxacillin for a paediatric outpatient parenteral antibiotic therapy service. J Pediatr Pharmacol Ther 2021 ; 51: 231-237.
4603	ziar	Vallée M, Barthélémy I, Friciu M, Pelletier E, Forest J.M, Benoit F, Leclair G. Compatibility of Lactated Ringer’s Injection With 94 Selected Intravenous Drugs During Simulated Y-site Administration. Hosp Pharm 2021 ; 56, 4: 228-234.
4831	ziar	Nezvalova-Henriksen K, Huseby Holm T, Nilsson N, Kjønniksen I, Tho I. Frequently acquired drugs in neonatal intensive care and their physical compatibility. Acta Paediatr 2022 ;111:2307–2314.
4837	ziar	De Silva, D.T.N Petrovski M, Strunk T, Mukadam N, Page‑Sharp N, Moore B.R, Batty K.T. Physicochemical compatibility of caffeine citrate and caffeine base injections with parenteral medications used in neonatal intensive care settings. Eur J Clin Pharmacol 2024 ; 80:1079–1087.

Mentions Légales